Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The conundrum of diabetic neuropathies—past, present, and future
L Ang, K Mizokami-Stout, SA Eid, M Elafros… - Journal of Diabetes and …, 2022 - Elsevier
Diabetic neuropathy (DN) remains arguably the most prevalent chronic complication in
people with both type 1 and type 2 diabetes, including in youth, despite changes in the …
people with both type 1 and type 2 diabetes, including in youth, despite changes in the …
Pathophysiology and treatment of gastrointestinal motility disorders in the acutely ill
Gastrointestinal dysmotility causes delayed gastric emptying, enteral feed intolerance, and
functional obstruction of the small and large intestine, the latter functional obstructions being …
functional obstruction of the small and large intestine, the latter functional obstructions being …
The contemporary prevalence of diabetic neuropathy in type 1 diabetes: findings from the T1D exchange
KR Mizokami-Stout, Z Li, NC Foster, V Shah… - Diabetes …, 2020 - diabetesjournals.org
OBJECTIVE To evaluate the contemporary prevalence of diabetic peripheral neuropathy
(DPN) in participants with type 1 diabetes in the T1D Exchange Clinic Registry throughout …
(DPN) in participants with type 1 diabetes in the T1D Exchange Clinic Registry throughout …
Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady‐state concentrations
KL Jones, LQ Huynh, S Hatzinikolas… - Diabetes, Obesity …, 2020 - Wiley Online Library
Aims To evaluate the effects of 8 weeks' administration of exenatide (EXE) once weekly on
gastric emptying of solids and liquids (using the “gold standard” technique, scintigraphy) …
gastric emptying of solids and liquids (using the “gold standard” technique, scintigraphy) …
Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes
KL Jones, RS Rigda, MDM Buttfield… - Diabetes, Obesity …, 2019 - Wiley Online Library
Aim To evaluate the effects of the prandial glucagon‐like peptide‐1 receptor agonist
lixisenatide on gastric emptying and blood pressure (BP) and superior mesenteric artery …
lixisenatide on gastric emptying and blood pressure (BP) and superior mesenteric artery …
Bariatric surgery induces a new gastric mucosa phenotype with increased functional glucagon-like peptide-1 expressing cells
L Ribeiro-Parenti, AC Jarry, JB Cavin… - Nature …, 2021 - nature.com
Abstract Glucagon-Like Peptide-1 (GLP-1) undergoes rapid inactivation by dipeptidyl
peptidase-4 (DPP4) suggesting that target receptors may be activated by locally produced …
peptidase-4 (DPP4) suggesting that target receptors may be activated by locally produced …
Optimal measurement of gastric emptying of solids in gastroparesis or functional dyspepsia: evidence to establish standard test
Objective Symptoms in gastroparesis (Gp) and functional dyspepsia (FD) overlap; using egg
protein substitute to measure gastric emptying of solids (GES),~ 40% of patients are …
protein substitute to measure gastric emptying of solids (GES),~ 40% of patients are …
Role of intestinal glucose absorption in glucose tolerance
Intestinal glucose absorption is integral to postprandial glucose homeostasis. Glucose
absorption is dependent on a number of factors, including the exposure of carbohydrate to …
absorption is dependent on a number of factors, including the exposure of carbohydrate to …
GLP-1 based therapies: clinical implications for gastroenterologists
The gut-derived incretin hormone, glucagon-like peptide 1 (GLP-1) lowers postprandial
blood glucose levels by stimulating insulin and inhibiting glucagon secretion. Two novel …
blood glucose levels by stimulating insulin and inhibiting glucagon secretion. Two novel …
Scintigraphy of Gastrointestinal Motility: Best Practices in Assessment of Gastric and Bowel Transit in Adults
Various radiologic examinations and other diagnostic tools exist for evaluating
gastrointestinal diseases. When symptoms of gastrointestinal disease persist and no …
gastrointestinal diseases. When symptoms of gastrointestinal disease persist and no …